SCHEMBL10669210

SCHEMBL10669210

CN1C(=O)C(=CC(=O)O)SC1=Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.50
▸ ITGB3 P05106 1/20 0.48
▸ ITGAV P06756 1/20 0.48
▸ MAPT P10636 6/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ PLA2G1B P04054 1/20 0.47
▸ ATG4B Q9Y4P1 1/20 0.47
▸ ALDH1A1 P00352 5/20 0.47
▸ PTP4A3 O75365 1/20 0.46
▸ POLB P06746 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ NSD2 O96028 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MCL1 Q07820 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10669207 1.00 PPARG (0.50) PPARGITGB3ITGAVMAPTMEN1
SCHEMBL10662770 0.83 FAAH (0.54) PPARGMAPTMEN1KMT2APLA2G1B
SCHEMBL10662771 0.83 FAAH (0.54) PPARGMAPTMEN1KMT2APLA2G1B
SCHEMBL10666251 0.82 S1PR1 (0.48) PPARGMAPTALDH1A1TDP1LMNA
SCHEMBL10666243 0.82 S1PR1 (0.48) PPARGMAPTALDH1A1TDP1LMNA
SCHEMBL10668341 0.72 FAAH (0.44) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL10668343 0.72 FAAH (0.44) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL14883357 0.69 ALDH1A1 (0.69) ITGB3ITGAVMAPTMEN1KMT2A
SCHEMBL10666221 0.69 FAAH (0.52) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL10666213 0.69 FAAH (0.52) MAPTMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4775677-A ANTIALLERGNES, ANTIINFLAMMATORY AGENTS, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1988-10-04 — — US disclosed
Send feedback